The Hidden Value: Why GSK Could Be the Defensive Stock to Watch in 2025
GSK plc is recognised for its resilience and innovation in the pharmaceutical sector, particularly in vaccines and respiratory therapies. The company is anticipated to make significant advances, particularly in cancer treatments for multiple myeloma. Analysts project a potential 30% upside for GSK’s
